Urocit (Potassium Citrate Extended-Release Tablets) Drug Information: Description, User Reviews, Drug Side Effects, Interactions

Pill Identifier Search

February 10, 2012

« Previous
1
2
3
4
5
6
7
8
9
10
next »

Urocit

Kidney Stones Slideshow Pictures

font size

Urocit®-K
(potassium citrate) Extended-Release Tablets for Oral Use

DRUG DESCRIPTION

Urocit®-K (potassium citrate extended-release tablets) is a citrate salt of potassium. Its empirical formula is K₃C₆H₅O₇ •H₂O, and it has the following chemical structure:

Urocit®-K (Potassium Citrate) Structural Formula Illustration

Urocit (potassium citrate extended-release tablets) ®-K yellowish to tan, oral wax-matrix tablets, contain 5 mEq (540 mg) potassium citrate, 10 mEq (1080 mg) potassium citrate and 15 mEq (1620 mg) potassium citrate each. Inactive ingredients include carnauba wax and magnesium stearate.

What are the precautions when taking potassium citrate extended-release tablets (Urocit)?

Before taking this medication, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.

This medication should not be used if you have certain medical conditions. Before using this medicine, consult your doctor or pharmacist if you have: underactive adrenal gland (Addison's disease), current bladder infection, uncontrolled diabetes, severe heart disease (e.g., recent heart attack, heart damage), certain stomach/intestinal problems (diabetic gastroparesis, conditions decreasing gut movement, peptic ulcer, blockage), severe kidney disease (e.g., inability to make urine), potassium-restricted diet, high...

Read All Potential Precautions of Urocit »

Last reviewed on RxList: 1/21/2010
This monograph has been modified to include the generic and brand name in many instances.